Source: International Congress 2019 – Advances in asthma pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Flajolet (London, United Kingdom), S. Bonvini (London, United Kingdom), B. Dekkak (London, United Kingdom), N. Kobold (London, United Kingdom), J. Adcock (Gothenburg, Sweden), P. Bradding (Leicester, United Kingdom), M. Belvisi (Gothenburg, Sweden), M. Birrell (Gothenburg, Sweden). Investigating Transient Receptor Potential V4 channel induced bronchospasm. 3875

Member's Comments

No comment yet.

Related content which might interest you: Modulation of Transient Receptor Potential Vanilloid-1 (TRPV1) response by inhaled prostaglandin-E2 and bradykinin Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction Year: 2018 Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020 Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Transient receptor potential ankyrin 1 (TRPA1)-mediated cough Source: Annual Congress 2011 - Translational models of disease Year: 2011 TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Transient receptor potential vanilloid 4 channels mediate resistive breathing-induced acute lung injury. Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Novel oral voltage-gated sodium channel (Nav) inhibitors inhibit capsaicin induced cough in conscious guinea pigs Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Loss of the calcium-sensing receptor (CaSR) decreases slowly-adapting receptor responsiveness to mechanical stretch independent of oxygenation status Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Classical transient receptor potential channel 6 (TRPC6) is a key regulator of acute hypoxic pulmonary vasoconstriction Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Late Breaking Abstract - Chronic Hypoxia Promotes Pulmonary Venous Smooth Muscle Cells Proliferation by Upregulating Calcium Sensing Receptor Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Broader Impact of IL-4Ra Blockade Than IL-5 Blockade on Type 2 Inflammation Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 LATE-BREAKING ABSTRACT: Inhibition of ATP-gated P2X3 channels by AF-219: An effective anti-tussive mechanism in chronic cough Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013 Clinical Evidence for Targeted Strategies in Asthma with Type 2 Inflammation: Single and Dual Inhibition Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics Year: 2017 Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease? Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Late Breaking Abstract - Contribution of STIM-activated TRPC-ORAI channels to the intermittent hypoxia-induced pulmonary hypertension Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Endogenous Anti-Inflammatory Mechanisms and the Role of Lipoxins Source: Research Seminar 2007 - Severe Asthma Year: 2007